Literature DB >> 27226586

Ajuba Phosphorylation by CDK1 Promotes Cell Proliferation and Tumorigenesis.

Xingcheng Chen1, Seth Stauffer1, Yuanhong Chen2, Jixin Dong3.   

Abstract

Recent studies identified the adaptor protein Ajuba as a positive regulator of Yes-associated protein (YAP) oncogenic activity through inhibiting large tumor suppressor (Lats1/2) core kinases of the Hippo pathway, a signaling pathway that plays important roles in cancer. In this study, we define a novel mechanism for phospho-regulation of Ajuba in mitosis and its biological significance in cancer. We found that Ajuba is phosphorylated in vitro and in vivo by cyclin-dependent kinase 1 (CDK1) at Ser(119) and Ser(175) during the G2/M phase of the cell cycle. Mitotic phosphorylation of Ajuba controls the expression of multiple cell cycle regulators; however, it does not affect Hippo signaling activity, nor does it induce epithelial-mesenchymal transition. We further showed that mitotic phosphorylation of Ajuba is sufficient to promote cell proliferation and anchorage-independent growth in vitro and tumorigenesis in vivo Collectively, our discoveries reveal a previously unrecognized mechanism for Ajuba regulation in mitosis and its role in tumorigenesis.
© 2016 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  Hippo pathway; cell proliferation; cyclin-dependent kinase (CDK); mitosis; phosphorylation; signal transduction

Mesh:

Substances:

Year:  2016        PMID: 27226586      PMCID: PMC4938193          DOI: 10.1074/jbc.M116.722751

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  52 in total

1.  A positive feedback loop between the p53 and Lats2 tumor suppressors prevents tetraploidization.

Authors:  Yael Aylon; Dan Michael; Ayelet Shmueli; Norikazu Yabuta; Hiroshi Nojima; Moshe Oren
Journal:  Genes Dev       Date:  2006-10-01       Impact factor: 11.361

2.  Cytokinesis failure triggers hippo tumor suppressor pathway activation.

Authors:  Neil J Ganem; Hauke Cornils; Shang-Yi Chiu; Kevin P O'Rourke; Jonathan Arnaud; Dean Yimlamai; Manuel Théry; Fernando D Camargo; David Pellman
Journal:  Cell       Date:  2014-08-14       Impact factor: 41.582

Review 3.  Hippo signaling in organ size control.

Authors:  Duojia Pan
Journal:  Genes Dev       Date:  2007-04-15       Impact factor: 11.361

4.  Hypoxia regulates Hippo signalling through the SIAH2 ubiquitin E3 ligase.

Authors:  Biao Ma; Yan Chen; Ling Chen; Hongcheng Cheng; Chenglong Mu; Jie Li; Ruize Gao; Changqian Zhou; Lei Cao; Jinhua Liu; Yushan Zhu; Quan Chen; Shian Wu
Journal:  Nat Cell Biol       Date:  2014-12-01       Impact factor: 28.824

Review 5.  The emerging roles of YAP and TAZ in cancer.

Authors:  Toshiro Moroishi; Carsten Gram Hansen; Kun-Liang Guan
Journal:  Nat Rev Cancer       Date:  2015-01-16       Impact factor: 60.716

6.  Ajuba LIM proteins are negative regulators of the Hippo signaling pathway.

Authors:  Meghna Das Thakur; Yunfeng Feng; Radhika Jagannathan; Midori J Seppa; James B Skeath; Gregory D Longmore
Journal:  Curr Biol       Date:  2010-03-18       Impact factor: 10.834

Review 7.  Heterogeneity of human colon carcinoma.

Authors:  M G Brattain; A E Levine; S Chakrabarty; L C Yeoman; J K Willson; B Long
Journal:  Cancer Metastasis Rev       Date:  1984       Impact factor: 9.264

8.  Phosphorylation of KIBRA by the extracellular signal-regulated kinase (ERK)-ribosomal S6 kinase (RSK) cascade modulates cell proliferation and migration.

Authors:  Shuping Yang; Ming Ji; Lin Zhang; Yuanhong Chen; Dirk Oliver Wennmann; Joachim Kremerskothen; Jixin Dong
Journal:  Cell Signal       Date:  2013-11-19       Impact factor: 4.315

Review 9.  Hippo Pathway in Organ Size Control, Tissue Homeostasis, and Cancer.

Authors:  Fa-Xing Yu; Bin Zhao; Kun-Liang Guan
Journal:  Cell       Date:  2015-11-05       Impact factor: 41.582

10.  Regulation of Hippo signaling by EGFR-MAPK signaling through Ajuba family proteins.

Authors:  B V V G Reddy; Kenneth D Irvine
Journal:  Dev Cell       Date:  2013-03-11       Impact factor: 12.270

View more
  19 in total

1.  Cyclin-dependent kinase 1 (CDK1)-mediated mitotic phosphorylation of the transcriptional co-repressor Vgll4 inhibits its tumor-suppressing activity.

Authors:  Yongji Zeng; Seth Stauffer; Jiuli Zhou; Xingcheng Chen; Yuanhong Chen; Jixin Dong
Journal:  J Biol Chem       Date:  2017-07-24       Impact factor: 5.157

2.  LncRNA CASC11 promoted gastric cancer cell proliferation, migration and invasion in vitro by regulating cell cycle pathway.

Authors:  Li Zhang; Wenquan Kang; Xiaolan Lu; Shiyang Ma; Lei Dong; Baicang Zou
Journal:  Cell Cycle       Date:  2018-09-10       Impact factor: 4.534

3.  Phosphoproteomics reveals that glycogen synthase kinase-3 phosphorylates multiple splicing factors and is associated with alternative splicing.

Authors:  Mansi Y Shinde; Simone Sidoli; Katarzyna Kulej; Michael J Mallory; Caleb M Radens; Amanda L Reicherter; Rebecca L Myers; Yoseph Barash; Kristen W Lynch; Benjamin A Garcia; Peter S Klein
Journal:  J Biol Chem       Date:  2017-09-15       Impact factor: 5.157

4.  CDK1-mediated mitotic phosphorylation of PBK is involved in cytokinesis and inhibits its oncogenic activity.

Authors:  Seth Stauffer; Yongji Zeng; Jiuli Zhou; Xingcheng Chen; Yuanhong Chen; Jixin Dong
Journal:  Cell Signal       Date:  2017-08-03       Impact factor: 4.315

5.  Cyclin-dependent kinase 1-mediated AMPK phosphorylation regulates chromosome alignment and mitotic progression.

Authors:  Seth Stauffer; Yongji Zeng; Montserrat Santos; Jiuli Zhou; Yuanhong Chen; Jixin Dong
Journal:  J Cell Sci       Date:  2019-10-28       Impact factor: 5.285

6.  Mutations of the LIM protein AJUBA mediate sensitivity of head and neck squamous cell carcinoma to treatment with cell-cycle inhibitors.

Authors:  Ming Zhang; Ratnakar Singh; Shaohua Peng; Tuhina Mazumdar; Vaishnavi Sambandam; Li Shen; Pan Tong; Lerong Li; Nene N Kalu; Curtis R Pickering; Mitchell Frederick; Jeffrey N Myers; Jing Wang; Faye M Johnson
Journal:  Cancer Lett       Date:  2017-01-23       Impact factor: 8.679

7.  PLOD3 regulates the expression of YAP1 to affect the progression of non-small cell lung cancer via the PKCδ/CDK1/LIMD1 signaling pathway.

Authors:  Wei-Hao Li; Kai Huang; Feng-Biao Wen; Guang-Hui Cui; Hai-Zhou Guo; Song Zhao
Journal:  Lab Invest       Date:  2022-01-17       Impact factor: 5.662

8.  MARK2 regulates chemotherapeutic responses through class IIa HDAC-YAP axis in pancreatic cancer.

Authors:  Yongji Zeng; Ling Yin; Jiuli Zhou; Renya Zeng; Yi Xiao; Adrian R Black; Tuo Hu; Pankaj K Singh; Feng Yin; Surinder K Batra; Fang Yu; Yuanhong Chen; Jixin Dong
Journal:  Oncogene       Date:  2022-07-02       Impact factor: 8.756

9.  Zyxin promotes colon cancer tumorigenesis in a mitotic phosphorylation-dependent manner and through CDK8-mediated YAP activation.

Authors:  Jiuli Zhou; Yongji Zeng; Lian Cui; Xingcheng Chen; Seth Stauffer; Zhan Wang; Fang Yu; Subodh M Lele; Geoffrey A Talmon; Adrian R Black; Yuanhong Chen; Jixin Dong
Journal:  Proc Natl Acad Sci U S A       Date:  2018-07-02       Impact factor: 11.205

10.  Cyclin-dependent kinase 1-mediated phosphorylation of YES links mitotic arrest and apoptosis during antitubulin chemotherapy.

Authors:  Zhan Wang; Xingcheng Chen; Mei-Zuo Zhong; Shuping Yang; Jiuli Zhou; David L Klinkebiel; Adam R Karpf; Yuanhong Chen; Jixin Dong
Journal:  Cell Signal       Date:  2018-09-15       Impact factor: 4.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.